These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 14677087)

  • 1. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders.
    Bauer M; Alda M; Priller J; Young LT;
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
    Manji HK; Moore GJ; Chen G
    J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium neuroprotection: molecular mechanisms and clinical implications.
    Rowe MK; Chuang DM
    Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroprotective actions of lithium].
    Hashimoto R; Fujimaki K; Jeong MR; Senatorov VV; Christ L; Leeds P; Chuang DM; Takeda M
    Seishin Shinkeigaku Zasshi; 2003; 105(1):81-6. PubMed ID: 12701214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate and neuroprotective effects for bipolar disorder.
    Atmaca M
    Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?
    Lagace DC; Eisch AJ
    Psychiatr Clin North Am; 2005 Jun; 28(2):399-414. PubMed ID: 15826739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium.
    Marmol F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1761-71. PubMed ID: 18789369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of lithium in neurodegenerative diseases: new registries for old actors].
    Pérez-Martínez DA
    Neurologia; 2009 Apr; 24(3):143-6. PubMed ID: 19418288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil.
    Takada-Takatori Y; Kume T; Ohgi Y; Izumi Y; Niidome T; Fujii T; Sugimoto H; Akaike A
    J Neurosci Res; 2008 Dec; 86(16):3575-83. PubMed ID: 18655200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
    Chuang DM
    Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the mechanism of action of lithium in the brain: fifty-year update.
    Lenox RH; Hahn CG
    J Clin Psychiatry; 2000; 61 Suppl 9():5-15. PubMed ID: 10826655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol.
    Colla M; Schubert F; Bubner M; Heidenreich JO; Bajbouj M; Seifert F; Luborzewski A; Heuser I; Kronenberg G
    Mol Psychiatry; 2009 Jul; 14(7):696-704, 647. PubMed ID: 18347601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
    Forlenza OV; De-Paula VJ; Diniz BS
    ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.
    Gould TD; Zarate CA; Manji HK
    J Clin Psychiatry; 2004 Jan; 65(1):10-21. PubMed ID: 14744163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium: a regeneration of interest.
    Roman MW
    Issues Ment Health Nurs; 2010 Nov; 31(11):753-4. PubMed ID: 20936899
    [No Abstract]   [Full Text] [Related]  

  • 17. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers.
    Manji HK; Moore GJ; Chen G
    Br J Psychiatry Suppl; 2001 Jun; 41():s107-19. PubMed ID: 11450170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria.
    Herrera F; Martin V; García-Santos G; Rodriguez-Blanco J; Antolín I; Rodriguez C
    J Neurochem; 2007 Feb; 100(3):736-46. PubMed ID: 17263795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.
    Lan MJ; McLoughlin GA; Griffin JL; Tsang TM; Huang JT; Yuan P; Manji H; Holmes E; Bahn S
    Mol Psychiatry; 2009 Mar; 14(3):269-79. PubMed ID: 18256615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the relevance of protein kinase C to lithium therapy in bipolar disorder].
    Sela B
    Harefuah; 2004 Jun; 143(6):414-6, 462. PubMed ID: 15524097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.